(Q50566426)

English

Optimizing dosage and duration therapy for chronic hepatitis C <<difficult-to-treat patients>>.

scientific article published in October 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/19034245

title

Optimizing dosage and duration therapy for chronic hepatitis C <<difficult-to-treat patients>>. (English)

1 reference

stated in

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/19034245

1 reference

José M Ladero

1

1 reference

stated in

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/19034245

publication date

1 October 2008

1 reference

stated in

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/19034245

published in

Annals of hepatology : official journal of the Mexican Association of Hepatology

1 reference

stated in

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/19034245

volume

7

1 reference

stated in

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/19034245

page(s)

392-394

1 reference

stated in

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/19034245

issue

4

1 reference

stated in

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/19034245

Identifiers

PubMed ID

19034245

1 reference

stated in

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/19034245

(Q50566426)

Optimizing dosage and duration therapy for chronic hepatitis C <<difficult-to-treat patients>>.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)